Presentation | Beyond LDL-C: Uncovering Residual Cardiovascular Risk and New Therapeutic Frontiers
Population
PCSK9 Inhibitors in Primary Cardiovascular Prevention: A Multi-Cohort Comparative Effectiveness Study of Evolocumab and Alirocumab versus Oral Dual Lipid-Lowering Therapy Using Real-World Electronic Health Records
Ahmad Assad, Univ of Central Florida, Gainesville, FL; Tala Altarawneh, Marshall Univ Sch of Med, Huntigton, WV; Abdallah Rayyan, Qusai Alqudah, Univ of Central Florida, Gainesville, FL; Ola Shaltout, Lahey Hosp and Medical Ctr, Boston, MA; Hamzeh Alshahwan, Univ of Central Florida / North Florida Hosp, Gainesville, FL; Adee Elhamdani, Marshall Univ Joan C Edwards Schl Med, Huntington, WV
